Cash & equivalents increased 42.6%
Cash & equivalents changed +42.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +42.6% from the comparable as-filed period.
Debt changed -67.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed -1070 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed -45.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -365.2% from the comparable as-filed period.
Operating income changed -298.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -5287 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +22.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -35.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory changed -17.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.